ArticleFrontiers in immunology2022

Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy.

Renato B Baleeiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.